BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26530476)

  • 21. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.
    Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
    Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
    Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
    Zinkevich OD; Mukhametova DD; Abdulganieva DI; Safina NA; Koporulina MO; Odintsova AKh
    Eksp Klin Gastroenterol; 2014; (10):22-7. PubMed ID: 25911926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
    De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
    Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
    Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced formation of advanced oxidation protein products in IBD.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.
    Yau YY; Leong RWL; Pudipeddi A; Redmond D; Wasinger VC
    Mol Cell Proteomics; 2017 Jul; 16(7):1244-1257. PubMed ID: 28490445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME
    Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
    Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
    Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.